BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2021-08-30 07:30 |
BRAIN Biotech AG 9M '20/'21 Results
|
English | HTML • 18.4 KB | ||
| 2021-08-30 00:00 |
Q3 statement / Q3 financial report 2020/2021
|
German | PDF • 1.6 MB | ||
| 2021-07-28 08:30 |
BRAIN Biotech AG: Sartorius and BRAIN jointly researching and adapting novel CR…
|
English | HTML • 11.3 KB | ||
| 2021-07-21 07:30 |
BRAIN Biotech AG: Novel Genome Editing Tool: Filing of International Patent App…
|
English | HTML • 10.8 KB | ||
| 2021-07-15 11:00 |
BRAIN Biotech AG: Additional CRISPR Genome Editing Nucleases Identified
|
English | HTML • 10.0 KB | ||
| 2021-06-08 11:00 |
BRAIN Biotech AG: BRAIN actively supports the UN Global Compact
|
English | HTML • 11.5 KB | ||
| 2021-05-31 15:55 |
DGAP-DD: BRAIN Biotech AG english
|
English | HTML • 8.0 KB | ||
| 2021-05-31 00:00 |
Half-yearly financial report 2020/2021
|
German | PDF • 1.9 MB | ||
| 2021-05-28 07:30 |
BRAIN Biotech AG H1 '20/'21 Results
|
English | HTML • 19.1 KB | ||
| 2021-05-14 17:02 | English | HTML • 3.8 KB | |||
| 2021-05-14 00:00 |
Hinweis auf Halbjahresfinanzbericht vom 01.10.2020 bis zum 31.03.2021
|
German | HTML • 5.8 KB | ||
| 2021-05-12 16:30 |
BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd.
|
English | HTML • 11.9 KB | ||
| 2021-05-06 18:00 |
BRAIN Biotech AG: Genome Editing Tool Developed by BRAIN
|
English | HTML • 11.3 KB | ||
| 2021-05-06 17:54 |
BRAIN Biotech AG: First Development Phase for a novel Genome Editing Tool Compl…
|
English | HTML • 7.7 KB | ||
| 2021-03-31 12:43 |
DGAP-DD: B.R.A.I.N. Biotechnology Research And Information Network AG english
|
English | HTML • 9.0 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
